Home
MEI Pharma

MEI Pharma Market Share Analysis for February 2026

Get LITS

Health > Biotechnology and Pharmaceuticals

Domainmeipharma.com

Year Founded2000

Employees51 - 200

Annual Revenue$50M - $75M

MEI Pharma

MEI Pharma (including company regionals)

meipharma.com

See more website traffic and engagement information

MEI Pharma Revenue up to February 2026 is 50M - 75M

revenue generated by MEI Pharma top domains

MEI Pharma top domains revenue over 3 years

Revenue for MEI Pharma top domains

meipharma.com50M - 75M

See more with Sales Intelligence

Total visits to MEI Pharma's top domains

Understand MEI Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

meipharma.com1.2K

See more with Sales Intelligence

Avg. visit duration in MEI Pharma's top domains

Analyze MEI Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

meipharma.com00:00:08

See more with Sales Intelligence

Avg. pageviews on MEI Pharma's top domains

See how MEI Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

meipharma.com1.25

See more with Sales Intelligence

MEI Pharma top competitors by domain

Top similar sites in February 2026, ranked by their affinity

mirati.comCompany NameMirati Therapeutics, Inc.Employees501 - 1000HQUnited States, California, San DiegoAnnual revenue$50M - $75MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by MEI Pharma

These are the website technologies, by industry, used by MEI Pharma top domains

Content Management System (4)

Drupal

Widget (4)

reCAPTCHA

Audio Video Media (3)

YouTube

Conversion & Analytics (3)

Google Analytics

More Technologies

8

See all

News & Signals from MEI Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMEI Pharma Inc. invests into assets: Litecoin assets in the amount of $100M.* MEI Pharma shifted to Lite Strategy with over $100 million in Litecoin assets.

NewsMEI Pharma Inc. hires Justin "Jay" File as Acting CEO.The board subsequently appointed CFO Justin "Jay" File as MEI's Acting CEO, who remains in the role.

NewsMEI Pharma Inc. invests into assets: 929,548 Litecoin units in the amount of $100M in United States, Northern America, Americas.MEI Pharma purchased 929,548 Litecoin units for $100 million, becoming the first publicly listed U.S. company to adopt LTC.